Wall Street Analysts Believe Candel Therapeutics (CADL) Could Rally 148.48%: Here's is How to Trade

Analysts’ mean price target for Candel Therapeutics (CADL) implies 148.5% upside, signaling bullish expectations for the stock. The article also notes broad agreement among analysts in raising earnings estimates, which supports a more positive outlook. The piece is commentary-focused rather than a new company event, so the likely market impact is limited.

Analysis

Analysts’ mean price target for Candel Therapeutics (CADL) implies 148.5% upside, signaling bullish expectations for the stock. The article also notes broad agreement among analysts in raising earnings estimates, which supports a more positive outlook. The piece is commentary-focused rather than a new company event, so the likely market impact is limited.